Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-intolerant”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Ended earlyNCT01602315
What this trial is testing

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 179
Testing effectiveness (Phase 2)Study completedNCT03833661
What this trial is testing

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer
EMD Serono Research & Development Institute, Inc. 159
Very early researchLooking for participantsNCT06496373
What this trial is testing

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Who this might be right for
Pancreatic Cancer ResectableChemotherapy-intolerant
Ruijin Hospital 20
Very early researchNot Yet RecruitingNCT07335094
What this trial is testing

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
B Lymphoblastic Leukemia/Lymphoma
Zhujiang Hospital 60
Not applicableStudy completedNCT00002405
What this trial is testing

Amprenavir in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Looking for participantsNCT07306624
What this trial is testing

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
STCube, Inc. 62
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728955
What this trial is testing

A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64
Testing effectiveness (Phase 2)UnknownNCT06260553
What this trial is testing

Metronomic Oral Vinorelbine Combination With Tislelizumab in EGFR/ALK-negative Advanced NSCLC

Who this might be right for
EGFR/ ALK-negative Advanced NSCLC
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02150967
What this trial is testing

A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma

Who this might be right for
Advanced CholangiocarcinomaFGFR2 Gene Mutation
QED Therapeutics, a BridgeBio company 143
Early research (Phase 1)Study completedNCT01801930
What this trial is testing

OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Who this might be right for
Colorectal Cancer
Otsuka Pharmaceutical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT03516071
What this trial is testing

Brivanib in Chinese Patients With Previously Treated Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zai Lab (Shanghai) Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT03274882
What this trial is testing

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

Who this might be right for
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier 26
Large-scale testing (Phase 3)Ended earlyNCT02117479
What this trial is testing

Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

Who this might be right for
Pancreatic Cancer
Incyte Corporation 321
Early research (Phase 1)Study completedNCT01820624
What this trial is testing

Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Paolo Caimi, MD 12
Testing effectiveness (Phase 2)UnknownNCT05896007
What this trial is testing

Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT

Who this might be right for
PCNSL
Ruijin Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06758037
What this trial is testing

Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy

Who this might be right for
DLBCLDiffuse Large B-Cell Lymphoma
First Affiliated Hospital of Ningbo University 50
Not applicableNot Yet RecruitingNCT07231809
What this trial is testing

Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients

Who this might be right for
Non Muscle Invasive Bladder CancerBladder CancerCarcinoma in Situ of Bladder+2 more
AC.TA. S.r.l. 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07746245
What this trial is testing

The Efficacy of CAPCT in Patients With PTCL

Who this might be right for
Peripheral T-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06669143
What this trial is testing

Zanubrutinib-based Maintenance Therapy of Newly Diagnosed DLBCL With Initial Remission

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 19
Testing effectiveness (Phase 2)Ended earlyNCT04501614
What this trial is testing

Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)Ph+ Mixed Phenotype Acute Leukemia (MPAL)Philadelphia Chromosome-Like ALL (Ph-like ALL)
Takeda 11
Next Page